Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Leukemia
•
CML
•
Hematology
Do you recommend antimicrobial prophylaxis in patients with CML blast crisis after 7+3 induction while on maintenance TKI awaiting allo transplant?
Related Questions
Would concurrent CRLF2/IgH rearrangement affect your treatment recommendations for an adult patient with Ph+ p190 high risk (Age>35, WBC >30) B-cell ALL that was started on induction therapy with ponatinib + blinatumomab?
Do you prefer quizartinib over midostaurin with chemotherapy induction for FLT3-ITD mutated AML given the results of QUANTUM-FIRST and preclinical advantages over other FLT3 inhibitors?
How would you manage an elderly patient with mild pancytopenia who refuses bone marrow biopsy and whose flow cytometry is suggestive of CMML/MDS?
What are your top takeaways in Hematologic Malignancies from ASCO 2023?
What is your approach to re-challenging BTK inhibitors for a patient who has had intolerance to several different agents?
What is your current approach to maintenance therapy in FLT3-mutant AML post allogeneic HCT?
How long do you continue ATRA during induction in high risk acute promyelocytic leukemia?
How would you treat an LGL leukemia patient who has been refractory to treatments with cyclosporine, MTX, and cyclophosphamide?
For AML patients, when do you stop antiinfective agents?
How has your approach to utilizing MRD-guided therapy in previously untreated CLL changed since the FLAIR trial, particularly in choosing between continuous versus time-limited treatment?
